ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9647
-0.11%
Brent Oil
83.06
-0.08%
Bitcoin
63,913.72
-0.13%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) Noticias

ANIP ANI Pharmaceuticals Inc

67.25
0.14 (0.21%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ANI Pharmaceuticals Inc ANIP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.14 0.21% 67.25 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
67.72 66.6467 67.93 67.25 67.11
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:30GLOBEANI Pharmaceuticals to Participate at Two Upcoming..
18/4/202415:05GLOBEANI Pharmaceuticals to Discuss First Quarter 2024 Financial..
09/4/202405:50GLOBEANI Pharmaceuticals Announces the Launch of Baclofen Oral..
04/4/202405:50GLOBEANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month..
03/4/202405:50GLOBEANI Pharmaceuticals to Participate at the Piper Sandler..
27/3/202405:50GLOBEANI Pharmaceuticals Announces the Launch of Levofloxacin..
08/3/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:59EDGAR2Form 144 - Report of proposed sale of securities
08/3/202415:26EDGAR2Form 144 - Report of proposed sale of securities
07/3/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:05EDGAR2Form 144 - Report of proposed sale of securities
06/3/202416:58EDGAR2Form 144 - Report of proposed sale of securities
06/3/202416:31EDGAR2Form 144 - Report of proposed sale of securities
06/3/202415:29EDGAR2Form 144 - Report of proposed sale of securities
06/3/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:00EDGAR2Form 144 - Report of proposed sale of securities
04/3/202418:18EDGAR2Form 144 - Report of proposed sale of securities
01/3/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202406:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202405:58EDGAR2Form 8-K - Current report
29/2/202405:50GLOBEANI Pharmaceuticals Reports Fourth Quarter and Record..
23/2/202415:51EDGAR2Form 8-K - Current report
20/2/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202405:50GLOBEANI Pharmaceuticals to Present at the Leerink Partners..
16/2/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202407:00EDGAR2Form 8-K - Current report
07/2/202405:50GLOBEANI Pharmaceuticals to Discuss Fourth Quarter and Full Year..
29/1/202405:50GLOBEANI Pharmaceuticals to Participate at the Guggenheim..
23/1/202417:14EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
ANIP
ANI Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados